Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Alan Homans"'
Autor:
Helen Mizrach, Brett Goshe, Elyse R Park, Christopher Recklitis, Joseph A Greer, Yuchiao Chang, Natasha Frederick, Annah Abrams, Mary D Tower, Emily A Walsh, Mary Huang, Lisa Kenney, Alan Homans, Karen Miller, John Denninger, Ghazala Naheed Usmani, Jeffrey Peppercorn, Giselle K Perez
Publikováno v:
JMIR Research Protocols, Vol 11, Iss 1, p e34033 (2022)
BackgroundThe emotional health of adolescent and young adult (AYA) cancer survivors is compromised both during and after cancer treatment. Targeted programs designed to support AYAs’ ability to cope with stress in the years following treatment comp
Externí odkaz:
https://doaj.org/article/7f656cff64ac44b38b180d1caa13abe4
Autor:
Helen Mizrach, Brett Goshe, Elyse R Park, Christopher Recklitis, Joseph A Greer, Yuchiao Chang, Natasha Frederick, Annah Abrams, Mary D Tower, Emily A Walsh, Mary Huang, Lisa Kenney, Alan Homans, Karen Miller, John Denninger, Ghazala Naheed Usmani, Jeffrey Peppercorn, Giselle K Perez
BACKGROUND The emotional health of adolescent and young adult (AYA) cancer survivors is compromised both during and after cancer treatment. Targeted programs designed to support AYAs’ ability to cope with stress in the years following treatment com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57b16eda6225a5b4d2f56b22b20d70ba
https://doi.org/10.2196/preprints.34033
https://doi.org/10.2196/preprints.34033
Autor:
Eric Sandler, Xiaomin Lu, Michael E. Kelly, George R. Buchanan, Alan Homans, Mark L. Bernstein, Thomas C. Abshire, Meenakshi Devidas, Bruce M. Camitta, Amy L. Billett
Publikováno v:
Journal of Pediatric Hematology/Oncology. 35:509-513
Pediatric patients who experience a bone marrow relapse of precursor-B acute lymphoblastic leukemia are cured < 50% of the time. This study was designed to determine if intensification of therapies with known activity in this disease would improve th
Autor:
Lisa Diller, Nina S. Kadan-Lottick, Alan Homans, Lisa B. Kenney, Heather A. Bradeen, Cindy L. Schwartz
Publikováno v:
Pediatric Blood & Cancer. 57:1062-1066
Background National guidelines for follow-up care of childhood cancer survivors have been established. It has not been determined if pediatric oncology programs have successfully incorporated these standards for long term survivor care into clinical
Autor:
Laurent Brard, Shannon R. Lenox, Peter M. Bingham, Taka Ashikaga, Ajay P. Singh, Alan Homans, Giselle Saulnier Sholler, Barton A. Kamen, Barry W. Heath, Marni A Slavik, Genevieve Bergendahl, Timothy Higgins, William S. Ferguson
Publikováno v:
Journal of Pediatric Hematology/Oncology. 33:25-30
The primary aim of this phase 1 study was to determine the maximum tolerated dose (MTD) and evaluate the safety of nifurtimox alone and in combination with cyclophosphamide and topotecan in multiple relapsed/refractory neuroblastoma pediatric patient
Autor:
Susan R. Durham, Alan Homans, Carl J. Nelson, Alissa A. Thomas, Suzanne Tucker, Joshua P. Nickerson
Publikováno v:
Pediatric Blood & Cancer. 66:e27465
Publikováno v:
Neuro-Oncology. 19:vi216-vi216
Anaplastic pleomorphic xanthoastrocytoma (PXA) is a newly recognized entity in the 2016 WHO classification of CNS tumors, characterized by elevated mitotic activity with or without necrosis, and shorter survival when compared with WHO grade II PXAs.
Autor:
Mary Eapen, Stella M. Davies, William L. Carroll, Elizabeth A. Raetz, Bruce M. Camitta, Catherine Muehlenbein, Thomas C. Abshire, Amy L. Billett, Alan Homans, Meenakshi Devidas, Mei-Jie Zhang
Publikováno v:
Blood. 107:4961-4967
The best treatment approach for children with B-precursor acute lymphoblastic leukemia (ALL) in second clinical remission (CR) after a marrow relapse is controversial. To address this question, we compared outcomes in 188 patients enrolled in chemoth
Autor:
Jeannine S. McCune, Lisa C. Iacono, Clinton F. Stewart, Denise M. Adams, Ann Guillot, Alan Homans
Publikováno v:
Journal of Pediatric Hematology/Oncology. 26:596-600
Although limited data are available about topotecan disposition in patients with renal insufficiency, nothing has been reported in anephric patients. The objective of this report is to characterize topotecan disposition in an anephric child with Wilm
Publikováno v:
Science. 288:514-517
T cells from patients who had received chemotherapy for B-lineage acute lymphocytic leukemia were studied to determine whether genetic instability, a principal characteristic of cancer cells, can also occur in nonmalignant cells. Consistent with expe